<p>此帖子可能包含我们赞助商和合作伙伴的链接，Flywheel Publishing 可能会因通过这些链接采取的行动而获得补偿。</p>
<p>媒体名人吉姆·克雷默（Jim Cramer）常常对公司发表大胆的言论，很多时候，他证明了自己的正确性。投资者密切关注他的股票推荐，并常常根据他选择的股票进行操作。虽然在股市中永远无法做到 100% 准确，但吉姆·克雷默已经多次命中目标。他本月挑选了两只大型股息股票作为热门买入。如果你是被动收入投资者，请继续关注我。克雷默建议购买 <strong>沃尔玛公司</strong>（NYSE: WMT）和 <strong>默克公司</strong>（NYSE: MRK）以获得稳定的被动收入。在这个故事中，我们讨论了这些股票的催化因素。</p>
<h2>本文的关键点：</h2>
<ul>
<li>吉姆·克雷默在投资界是一个受欢迎的名字。</li>
<li>他建议投资制药公司默克和零售商沃尔玛，以获得稳定的上涨和被动收入。</li>
<li>今年有 400 万美国人即将退休。如果你想加入他们，请立即点击这里查看你是落后还是领先。只需一分钟。（赞助商）</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2022/10/imageForEntry3-0fO.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2022/10/imageForEntry3-0fO.jpg"/></p>
<h2>沃尔玛</h2>
<p>作为领先的零售商，沃尔玛及时采取了行动，进入电子商务领域以留住客户，并从未回头。克雷默称这只股票为 “惊人”。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>尽管面临关税担忧，沃尔玛在过去一个月上涨了 8%，一年内上涨了 79%。目前股价为 101 美元，该股票正在上涨，并享有强劲的势头。吉姆·克雷默认为沃尔玛是零售行业中最具价值的股票。在 2023 年 11 月，他表示：“我忠于价值，而沃尔玛为我提供了价值，这就是为什么沃尔玛的股票可能在今年上涨 66% 并仍在攀升。”</p>
<p>有趣的是，该股票在一年内上涨了超过 66%，证明了克雷默的正确性。公司预计今年将实现稳健的增长。广告收入预计将增长，并可能创下公司的新纪录。公司还开始使用无人机送货，以覆盖更多目的地，并正在开发基于生成式人工智能的聊天机器人，以使购物体验个性化。沃尔玛还在扩大其电子商务市场份额，并对 <strong>亚马逊</strong>（NASDAQ:AMZN）形成了强有力的竞争。电子商务领域存在巨大的机会，沃尔玛在这里充分利用这一机会。如果你在寻找被动收入，该公司的股息收益率为 0.81%，并且已经连续 51 年增加股息。</p>
<p>在第三季度，沃尔玛报告收入为 1695.9 亿美元，每股收益为 58 美分。可比销售额增长了 5.3%，而美国电子商务销售额跃升了 22%。管理层在出色的季度业绩后提高了前景，因为他们预计消费者在假日季节的支出将增加。公司所提供的购买优惠吸引了富裕客户，他们不断回头。公司还对一些门店进行了改造，使其看起来像一家高档百货商店。</p>
<p>瑞银分析师对该股票的目标价为 113 美元，评级为买入，而美银分析师的目标价为 110 美元，评级为买入。摩根士丹利的目标价为 106 美元，评级为增持，奥本海默分析师的目标价也为 110 美元，评级为跑赢大盘。分析师预计公司将在第四季度报告强劲的业绩。</p>
<p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/06/imageforentry3-jko.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/06/imageforentry3-jko.jpg"/></p>
<h2>默克</h2>
<p>克雷默是医疗保健股票的长期投资者，并认为默克是一个理想的选择。早在 1 月，他就解释说，默克并没有得到足够的认可，尽管他们的投资组合和新疗法。尽管目前制药公司的前景可能并不光明，但他强调了它们所提供的强大和有利可图的潜力。他补充道：“我为什么如此愿意关注所谓的未来年份？因为这些公司的长期可能性，坦率地说，令人难以置信，而且顺便说一下，利润也非常可观，即使现在的情况不错，但并不伟大。”</p>
<p>目前股价为 87 美元，该股票在最近公布的业绩后下跌。总体而言，今年下跌了 30%，年初至今下跌了 11%。华尔街分析师下调了该股票的目标价，使其在下跌中成为强劲买入。</p>
<p>在第四季度，默克报告总销售额为 156 亿美元，同比增长 7%，净收入为 37.4 亿美元，较去年同期的亏损有所增加。管理层预计 2025 年的销售额为 656 亿美元，低于预期。默克最大的增长动力是其癌症药物 Keytruda，其专利将在 2028 年到期。这可能导致明年的销售下降，除非默克找到扭转销售的办法。其 HPV 疫苗 Gardasil 在中国市场表现强劲，但近期的关税可能会对公司造成干扰。然而，该疫苗最近获得了男性使用的批准，这可能会推动公司的收入。</p>
<p>默克拥有令人印象深刻的药物管线，未来几年将继续为业务产生现金流。临床试验的增加以及正在进行的试验将使公司受益。公司的投资者演示文稿显示出 20 个增长驱动因素，具有转变为重磅药物的潜力。此外，预计到 2030 年代中期，默克还将扩大在传染病和动物健康领域的市场份额。</p>
<p>该公司享有 3.71% 的股息收益率，并且已经连续 15 年增加股息。</p>
<p>这篇文章《吉姆·克雷默表示这两只大型股息股票是热门的二月买入》最早出现在 24/7 Wall St.。</p>

沃尔玛

默克

<p>吉姆·克莱默推荐了两只适合二月份的大型股息股票：沃尔玛公司（NYSE: WMT）和默克公司（NYSE: MRK）。沃尔玛表现强劲，过去一个月上涨了 8%，一年内上涨了 79%，这得益于电子商务的增长和创新策略。它的股息收益率为 0.81%，并且连续 51 年增加股息。尽管默克近期面临挑战，但在医疗保健领域的长期潜力被积极看待。克莱默强调这两只股票为被动收入投资者提供了丰厚的机会</p>

<p>This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.</p>
<div class="lb-trans"><p>此帖子可能包含我们赞助商和合作伙伴的链接，Flywheel Publishing 可能会因通过这些链接采取的行动而获得补偿。</p>
</div><p>Media personality Jim Cramer often makes bold statements about companies and a lot of times, he proves himself correct. Investors keep an eye on his stock recommendations and often make their moves based on the stocks he picks. While one can never be 100% accurate in the stock market, Jim Cramer has managed to hit the bull’s eye several times. He has picked two large-cap dividend stocks as hot buys this month. If you are a passive income investor, stay with me. Cramer recommends buying <strong>Walmart Inc.</strong> (NYSE: WMT) and <strong>Merck &amp; Co. Inc.</strong> (NYSE: MRK) for steady passive income. In this story, we discuss the catalysts working for the stocks.</p>
<div class="lb-trans"><p>媒体名人吉姆·克雷默（Jim Cramer）常常对公司发表大胆的言论，很多时候，他证明了自己的正确性。投资者密切关注他的股票推荐，并常常根据他选择的股票进行操作。虽然在股市中永远无法做到 100% 准确，但吉姆·克雷默已经多次命中目标。他本月挑选了两只大型股息股票作为热门买入。如果你是被动收入投资者，请继续关注我。克雷默建议购买 <strong>沃尔玛公司</strong>（NYSE: WMT）和 <strong>默克公司</strong>（NYSE: MRK）以获得稳定的被动收入。在这个故事中，我们讨论了这些股票的催化因素。</p>
</div><h2>Key points in this article:</h2>
<div class="lb-trans"><h2>本文的关键点：</h2>
</div><ul>
<li>Jim Cramer is a popular name in the world of investing.</li>
<li>He recommends investing in drug maker Merck and retailer Walmart for steady upside and passive income.</li>
<li>4 million Americans are set to retire this year. If you want to join them, click here now to see if you’re behind, or ahead. It only takes a minute. (Sponsor)</li>
</ul>
<div class="lb-trans"><ul>
<li>吉姆·克雷默在投资界是一个受欢迎的名字。</li>
<li>他建议投资制药公司默克和零售商沃尔玛，以获得稳定的上涨和被动收入。</li>
<li>今年有 400 万美国人即将退休。如果你想加入他们，请立即点击这里查看你是落后还是领先。只需一分钟。（赞助商）</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2022/10/imageForEntry3-0fO.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2022/10/imageForEntry3-0fO.jpg"/></p>
<h2>Walmart</h2>
<div class="lb-trans"><h2>沃尔玛</h2>
</div><p>A leading retailer, Walmart made timely moves and entered the e-commerce business to retain customers and has never looked back. Cramer calls the stock “Amazing”.</p>
<div class="lb-trans"><p>作为领先的零售商，沃尔玛及时采取了行动，进入电子商务领域以留住客户，并从未回头。克雷默称这只股票为 “惊人”。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2025/01/Follow-Our-500000-AI-Portfolio-3.jpg"/></p>
<p>Despite tariff concerns, Walmart is up 8% in the past month and 79% over the year. Trading for $101, the stock is on a rally and is enjoying solid momentum. Jim Cramer thinks Walmart is the best value player in the retail industry. In November 2023, he stated, “I am loyal to value and Walmart is offering me value and that’s why Walmart stock could be up 66% for the year and still climbing.”</p>
<div class="lb-trans"><p>尽管面临关税担忧，沃尔玛在过去一个月上涨了 8%，一年内上涨了 79%。目前股价为 101 美元，该股票正在上涨，并享有强劲的势头。吉姆·克雷默认为沃尔玛是零售行业中最具价值的股票。在 2023 年 11 月，他表示：“我忠于价值，而沃尔玛为我提供了价值，这就是为什么沃尔玛的股票可能在今年上涨 66% 并仍在攀升。”</p>
</div><p>Interestingly, the stock gained more than 66% over the year, proving Cramer right. The company is set to make solid gains this year. The ad revenue is expected to grow and could hit a new record for the company. The company has also started to use drone delivery to reach more destinations and it is working on generative-AI powered chatbots to make the shopping experience personalized. Walmart is also growing its e-commerce market share and is giving strong competition to <strong>Amazon</strong>(NASDAQ:AMZN). There is massive opportunity in the e-commerce space and Walmart is here to make the most of it. If you are here for the passive income, the company has a dividend yield of 0.81% and it has increased dividends for the past 51 consecutive years.</p>
<div class="lb-trans"><p>有趣的是，该股票在一年内上涨了超过 66%，证明了克雷默的正确性。公司预计今年将实现稳健的增长。广告收入预计将增长，并可能创下公司的新纪录。公司还开始使用无人机送货，以覆盖更多目的地，并正在开发基于生成式人工智能的聊天机器人，以使购物体验个性化。沃尔玛还在扩大其电子商务市场份额，并对 <strong>亚马逊</strong>（NASDAQ:AMZN）形成了强有力的竞争。电子商务领域存在巨大的机会，沃尔玛在这里充分利用这一机会。如果你在寻找被动收入，该公司的股息收益率为 0.81%，并且已经连续 51 年增加股息。</p>
</div><p>In the third quarter, Walmart reported a revenue of $169.59 billion and an EPS of 58 cents. The comparable sales increased 5.3% while the U.S. e-commerce sales jumped 22%. Management hiked the outlook after stellar quarterly results as they expect consumers to spend more during the holiday season. What worked for the company was the perks it offered on purchases which attracted affluent customers who kept coming back. It also overhauled some of its stores to make them look like a sophisticated department store.</p>
<div class="lb-trans"><p>在第三季度，沃尔玛报告收入为 1695.9 亿美元，每股收益为 58 美分。可比销售额增长了 5.3%，而美国电子商务销售额跃升了 22%。管理层在出色的季度业绩后提高了前景，因为他们预计消费者在假日季节的支出将增加。公司所提供的购买优惠吸引了富裕客户，他们不断回头。公司还对一些门店进行了改造，使其看起来像一家高档百货商店。</p>
</div><p>UBS analyst has a price target of $113 for the stock with a buy rating while BoFa analyst has a price target of $110 and a buy rating. Morgan Stanley has a price target of $106 with an overweight rating and Oppenheimer analyst also has a price target of $110 with an outperform rating. The analyst expects the company to report strong Q4 performance.</p>
<div class="lb-trans"><p>瑞银分析师对该股票的目标价为 113 美元，评级为买入，而美银分析师的目标价为 110 美元，评级为买入。摩根士丹利的目标价为 106 美元，评级为增持，奥本海默分析师的目标价也为 110 美元，评级为跑赢大盘。分析师预计公司将在第四季度报告强劲的业绩。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://247wallst.com/wp-content/uploads/2019/06/imageforentry3-jko.jpg" alt="" original-src="https://247wallst.com/wp-content/uploads/2019/06/imageforentry3-jko.jpg"/></p>
<h2>Merck</h2>
<div class="lb-trans"><h2>默克</h2>
</div><p>Cramer is a long-term investor in healthcare stocks and considers Merck to be an ideal pick. Earlier in Jan, he explained that Merck wasn’t getting enough credit for their portfolios and the new treatments. The present outlook for pharmaceutical companies might not be stellar but he highlighted the strong and lucrative potential they offer. He added, “Why am I so willing to focus on the so-called out years? Because the long-term possibilities for these companies, frankly, they’re incredible and by the way, incredibly lucrative too, even as the present is good, but not great.”</p>
<div class="lb-trans"><p>克雷默是医疗保健股票的长期投资者，并认为默克是一个理想的选择。早在 1 月，他就解释说，默克并没有得到足够的认可，尽管他们的投资组合和新疗法。尽管目前制药公司的前景可能并不光明，但他强调了它们所提供的强大和有利可图的潜力。他补充道：“我为什么如此愿意关注所谓的未来年份？因为这些公司的长期可能性，坦率地说，令人难以置信，而且顺便说一下，利润也非常可观，即使现在的情况不错，但并不伟大。”</p>
</div><p>Trading at $87, the stock sank after the recently announced results. Overall, it is down 30% in the year and 11% year-to-date. Wall Street analysts have lowered the price target of the stock, making it a strong buy in the dip.</p>
<div class="lb-trans"><p>目前股价为 87 美元，该股票在最近公布的业绩后下跌。总体而言，今年下跌了 30%，年初至今下跌了 11%。华尔街分析师下调了该股票的目标价，使其在下跌中成为强劲买入。</p>
</div><p>For the fourth quarter, Merck reported total sales of $15.6 billion, up 7% year-over-year, and a net income of $3.74 billion, up from a loss in the same quarter the previous year. For 2025, the management is forecasting sales of $65.6 billion, below expectations. The biggest growth driver for Merck is its cancer drug, Keytruda, and its patent is set to expire in 2028. This might lead to a drop in sales in the coming year unless Merck figures out a way to turn the sales around. Its HPV vaccine, Gardasil is a strong player in the China market but the recent tariffs can disrupt the same for the company. However, the vaccine was recently approved for men which can give a boost to the company’s revenue.</p>
<div class="lb-trans"><p>在第四季度，默克报告总销售额为 156 亿美元，同比增长 7%，净收入为 37.4 亿美元，较去年同期的亏损有所增加。管理层预计 2025 年的销售额为 656 亿美元，低于预期。默克最大的增长动力是其癌症药物 Keytruda，其专利将在 2028 年到期。这可能导致明年的销售下降，除非默克找到扭转销售的办法。其 HPV 疫苗 Gardasil 在中国市场表现强劲，但近期的关税可能会对公司造成干扰。然而，该疫苗最近获得了男性使用的批准，这可能会推动公司的收入。</p>
</div><p>Merck has an impressive drug pipeline that will continue to generate cash flow for the business in the coming years. An increase in clinical trials in addition to the trials in progress can benefit the company. The company’s investor presentation showed 20 growth drivers that have the potential to turn into blockbuster drugs. Additionally, it also expects to expand the market share in infectious disease and animal health by mid-2030s.</p>
<div class="lb-trans"><p>默克拥有令人印象深刻的药物管线，未来几年将继续为业务产生现金流。临床试验的增加以及正在进行的试验将使公司受益。公司的投资者演示文稿显示出 20 个增长驱动因素，具有转变为重磅药物的潜力。此外，预计到 2030 年代中期，默克还将扩大在传染病和动物健康领域的市场份额。</p>
</div><p>The company enjoys a dividend yield of 3.71% and has increased dividends for 15 consecutive years.</p>
<div class="lb-trans"><p>该公司享有 3.71% 的股息收益率，并且已经连续 15 年增加股息。</p>
</div><p>The post Jim Cramer Says These 2 Large Cap Dividend Stocks Are Hot February Buys appeared first on 24/7 Wall St..</p>
<div class="lb-trans"><p>这篇文章《吉姆·克雷默表示这两只大型股息股票是热门的二月买入》最早出现在 24/7 Wall St.。</p>
</div>

Jim Cramer Says These 2 Large Cap Dividend Stocks Are Hot February Buys

- Jim Cramer 推荐沃尔玛和默克作为稳定的被动收入投资。  
- 沃尔玛在电商领域表现强劲，股价上涨 79%。  
- 默克的癌症药物 Keytruda 是主要增长动力，预计未来有潜力。

吉姆·克莱默表示，这两只大盘股息股票是二月份的热门买入选择